.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
QuintilesIMS
Baxter
Merck
Covington
McKinsey
Cantor Fitzgerald
Medtronic
Farmers Insurance
Daiichi Sankyo

Generated: June 24, 2017

DrugPatentWatch Database Preview

MALATHION Drug Profile

« Back to Dashboard

What is the patent landscape for Malathion, and what generic Malathion alternatives are available?

Malathion is a drug marketed by Mylan Pharms Inc and Suven Life and is included in two NDAs.

The generic ingredient in MALATHION is malathion. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the malathion profile page.

Summary for Tradename: MALATHION

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list42
Clinical Trials: see list7
Patent Applications: see list3,930
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MALATHION at DailyMed

Pharmacology for Tradename: MALATHION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
MALATHION
malathion
LOTION;TOPICAL078743-001Mar 6, 2009DISCNNoNo► Subscribe► Subscribe
Suven Life
MALATHION
malathion
LOTION;TOPICAL091559-001May 23, 2012ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Queensland Health
McKinsey
Express Scripts
UBS
Daiichi Sankyo
Farmers Insurance
Novartis
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot